Trueblood Wealth Management LLC Makes New Investment in Astera Labs, Inc. $ALAB

Key Points

• Trueblood Wealth Management LLC acquired a new investment in Astera Labs, purchasing 2,500 shares valued at approximately $226,000 during the 2nd quarter.
• Astera Labs recently reported earnings of $0.44 per share, significantly surpassing the anticipated $0.33, with revenues of $191.93 million for the quarter.
• Research analysts have given Astera Labs an average rating of "Moderate Buy" with a consensus target price of $159.83, despite some mixed ratings from different firms.

Trueblood Wealth Management LLC bought a new position in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 2,500 shares of the company's stock, valued at approximately $226,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Oliver Lagore Vanvalin Investment Group bought a new position in shares of Astera Labs in the second quarter worth about $29,000. Sound Income Strategies LLC raised its stake in shares of Astera Labs by 34.7% in the first quarter. Sound Income Strategies LLC now owns 792 shares of the company's stock worth $47,000 after buying an additional 204 shares during the period. GAMMA Investing LLC raised its stake in shares of Astera Labs by 55.7% in the first quarter. GAMMA Investing LLC now owns 794 shares of the company's stock worth $47,000 after buying an additional 284 shares during the period. Harbour Investments Inc. raised its stake in shares of Astera Labs by 351.7% in the first quarter. Harbour Investments Inc. now owns 795 shares of the company's stock worth $47,000 after buying an additional 619 shares during the period. Finally, Migdal Insurance & Financial Holdings Ltd. bought a new position in shares of Astera Labs in the first quarter worth about $48,000. 60.47% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on ALAB shares. Northland Securities downgraded Astera Labs from an "outperform" rating to a "market perform" rating and set a $120.00 price objective on the stock. in a research note on Tuesday, July 22nd. TD Cowen initiated coverage on Astera Labs in a research note on Wednesday, October 1st. They set a "hold" rating and a $200.00 target price on the stock. Evercore ISI lifted their target price on Astera Labs from $104.00 to $215.00 and gave the company an "outperform" rating in a research note on Wednesday, August 6th. Jefferies Financial Group lifted their target price on Astera Labs from $95.00 to $130.00 and gave the company a "buy" rating in a research note on Tuesday, July 22nd. Finally, Bank of America initiated coverage on Astera Labs in a research note on Friday, October 3rd. They set a "neutral" rating and a $230.00 target price on the stock. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat.com, Astera Labs currently has an average rating of "Moderate Buy" and a consensus target price of $159.83.

Astera Labs Price Performance

NASDAQ:ALAB opened at $212.10 on Wednesday. Astera Labs, Inc. has a 1 year low of $47.13 and a 1 year high of $262.90. The stock's 50 day simple moving average is $193.63 and its two-hundred day simple moving average is $121.53. The company has a market cap of $35.26 billion, a price-to-earnings ratio of 378.75, a PEG ratio of 5.50 and a beta of 1.43.

Astera Labs (NASDAQ:ALAB - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported $0.44 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.33 by $0.11. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.The business had revenue of $191.93 million for the quarter, compared to the consensus estimate of $172.46 million. During the same quarter in the previous year, the company posted $0.13 EPS. The company's revenue was up 149.5% compared to the same quarter last year. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. As a group, analysts anticipate that Astera Labs, Inc. will post 0.34 EPS for the current year.

Insiders Place Their Bets

In other Astera Labs news, Director Manuel Alba sold 183,000 shares of Astera Labs stock in a transaction that occurred on Tuesday, September 2nd. The stock was sold at an average price of $173.27, for a total value of $31,708,410.00. Following the sale, the director owned 385,863 shares of the company's stock, valued at $66,858,482.01. The trade was a 32.17% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, General Counsel Philip Mazzara sold 10,000 shares of Astera Labs stock in a transaction that occurred on Wednesday, October 1st. The stock was sold at an average price of $192.16, for a total value of $1,921,600.00. Following the completion of the sale, the general counsel directly owned 151,573 shares in the company, valued at approximately $29,126,267.68. The trade was a 6.19% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 1,320,054 shares of company stock worth $215,638,632. Insiders own 12.50% of the company's stock.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.